Senior Director Team Lead U.S. Meningococcal Marketing

ROLE SUMMARY

Vaccines is the only place in Pfizer where you can contribute to patients in a way like no other you can help prevent sickness and disease. This is at the heart of what drives us every day and brings us great # exciting time to be in US Vaccines with one of the strongest pipelines in the industry and with multiple product launches.

Invasive Meningococcal Disease (IMD) is an uncommon but serious illness that can lead to death within 24 hours. About 1 in 10 people infected with IMD will die. Up to 1 in 5 survivors will have long-term devastating consequences such as limb amputationnerveand brain damage. Today there are separate complex vaccination recommendations forMenACWYandMenB. 70% of adolescents in the US have incomplete protection against IMD caused byserogroupsABCWY.

ROLE RESPONSIBILITES

Pfizer Vaccines has one of the strongest pipelines in the industry with multiple new products poised to come to market in the next few years. With these potential vaccines on the horizon the U.S. meningococcal portfolio will play a key role in delivering break-throughs that change patients lives and portfolio growth. The licensed U.S. meningococcal portfolio is currently comprised of a meningitis (men) B vaccine TRUMENBA. Additionally as part of the portfolio PENBRAYA (pentavalent) launched in 2024 providing protection for men ACWY and B to simplify the adolescent vaccine schedule.

• Develop uptake plans for the Meningococcal franchise in different market segments to drive market development toestablishproduct differentiation and to maximize commercial success. Thisrequiresstrong franchise portfolio planningidentifyingunderlying synergies and interdependencies inplanning;including product forecasting positioning pricing strategy and access planning product life cycle strategy competitor defense ACIP recommendation scenario planning managing marketing collaborations.
• Responsibilities and leadership expectations for the US Meningococcal Lead:
• Establish and lead the team and US commercial strategies for Pfizers Meningococcal franchise (PENBRAYA and TRUMENBA).
• Lead the development of forecasts plans strategies and operational commitments (Op Plan) and ensure delivery of all Op Plan commitments
• Lead the preparation of a successful evidence-based patients first strategy to successfully differentiate and defend against competitors
• Ensure strong collaboration with the US sales and accounts team to ensure seamless execution of the launch strategies into customer-facing activities.
• Ensure strong collaboration with Prevnar PediatricsandABRYSVO MaternalfranchiseUS marketing teams for effective strategic and tactical coordination by customer segment/channel to maximize our vaccines portfolio opportunities.
• Operate and lead within a highly matrixed environment ensuring seamless collaboration with Vaccines Consumer and Market Shaping teams as well as the Chief Marketing Office
• Lead long term strategic planning for potential/future meningococcal vaccine platform changes
• Build a high performing team through the ability to attract engagecoachand develop the best talent while modeling our Values of Courage Excellence Equity and Joy
• Collaborate and provide thought leadership within the team but also across the US Vaccines business on innovative models to enhance our growth opportunities
• Participate and contribute as an active enterprise leader in the U.S. Pediatric Vaccines Portfolio Leadership Team.

BASIC QUALIFICATIONS

• Bachelors degreeand 12or more years ofexperience 10 years with MBA
• US pharmaceutical experience
• Strong familiarity with US marketing landscape including HCPs Medical Groups / Integrated Delivery Networks (IDNs) Payers Group Purchasing Organizations (GPOs)and Physician Buying Groups (PBGs)
• Previousteam leadership experiencerequired
• Demonstrated ability to lead cross-functional teams
• Financialexpertiseto be able to build revenue forecast scenarios and plan associated commercial model implications
• Strong project and process management skills along with the ability to work on multiple tasks and to prioritize effectively
• Demonstrated initiative creativity strategic capabilities and strong analytical and leadership skills
• Demonstrated effective decision-making
• Track-record of active contribution to create andoperatein an environment that continuously embraces and encourages the implementation of innovative ideas
• Proven collaboration skills to effectively influence guide coachpeersand other colleagues to achieve meaningful outcomes and create positive business impact
• Ability to bring strategy and analysis to a tactical executable level; results-oriented
• Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers develop and coach others oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

PREFERRED QUALIFICATIONS

• Preference for vaccines experience
• Relevant prior launch experience a plus
• Advanced degree preferred

Last Day to Apply: January 22 2026

Location: Hybrid NYHQ/CV

Relocation assistance may be available based on business needs and/or eligibility.